Information  X 
Enter a valid email address

Dunedin Inc.Growth (DIG)

  Print      Mail a friend       Annual reports

Friday 13 September, 2019

Dunedin Inc.Growth

Director/PDMR Shareholding

RNS Number : 3412M
Dunedin Income Growth Inv Tst PLC
13 September 2019
 

Dunedin Income Growth Investment Trust PLC

Legal Entity Identifier:  549300PPXLZPR5JTL763

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

MR HOWARD WILLIAMS

2

Reason for the notification

a)

Position/status

NON EXECUTIVE DIRECTOR

b)

Initial notification/ Amendment

INITIAL NOTIFICATION

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

DUNEDIN INCOME GROWTH INVESTMENT TRUST PLC

b)

LEI

549300PPXLZPR5JTL763

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

ORDINARY 25P SHARES


GB0003406096

b)

Nature of the transaction

DIVIDEND REINVESTMENT

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£2.693267

107

d)

Aggregated information

 - Aggregated volume

- Price

 

107 ORDINARY SHARES OF 25P EACH

£288.18 TOTAL PRICE

e)

Date of the transaction

12/09/19

f)

Place of the transaction

LONDON STOCK EXCHANGE, MAIN MARKET (XLON)

 

Following this transaction the total beneficial Interest for MR HOWARD WILLIAMS is 10,756 Ordinary 25p Shares


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHLLFVSAAIVLIA

a d v e r t i s e m e n t